Skalickova, S.; Loffelmann, M.; Gargulak, M.; Kepinska, M.; Docekalova, M.; Uhlirova, D.; Stankova, M.; Fernandez, C.; Milnerowicz, H.; Ruttkay-Nedecky, B.;
et al. Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery. Nanomaterials 2017, 7, 435.
https://doi.org/10.3390/nano7120435
AMA Style
Skalickova S, Loffelmann M, Gargulak M, Kepinska M, Docekalova M, Uhlirova D, Stankova M, Fernandez C, Milnerowicz H, Ruttkay-Nedecky B,
et al. Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery. Nanomaterials. 2017; 7(12):435.
https://doi.org/10.3390/nano7120435
Chicago/Turabian Style
Skalickova, Sylvie, Martin Loffelmann, Michael Gargulak, Marta Kepinska, Michaela Docekalova, Dagmar Uhlirova, Martina Stankova, Carlos Fernandez, Halina Milnerowicz, Branislav Ruttkay-Nedecky,
and et al. 2017. "Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery" Nanomaterials 7, no. 12: 435.
https://doi.org/10.3390/nano7120435
APA Style
Skalickova, S., Loffelmann, M., Gargulak, M., Kepinska, M., Docekalova, M., Uhlirova, D., Stankova, M., Fernandez, C., Milnerowicz, H., Ruttkay-Nedecky, B., & Kizek, R.
(2017). Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery. Nanomaterials, 7(12), 435.
https://doi.org/10.3390/nano7120435